Boldenone Undecylenate injection
COMPOSITION
Each ml contains:
Boldenone Undecylenate 200 mg
Oil base q.s.
Indications and usage:
Dynabold is indicated for replacement therapy in the male in conditions associated with symptoms of deficiency or absence of endogenous testosterone.
- Primary hypo gonad.ism ( congential or acquired-testicular failure due to cryptorchidism, bilateral torsion, orchitis, vanishing testis syndrome, or orchidectomy.)
- Hypogonadotropic hypo gonad.ism ( congenital or acquired)-idiopathic gonadotropin or LHRH deficiency, or pituitary-hypothalamic injury from tumours, trauma, or radiation.
Contraindications:
- Known hypersensitivity to the drug.
- Males with carcinoma of the breast.
- Males withknown or suspected carcinoma oftheprostategland.
- Women who are or who may become pregnant.
- Patients with serious cardiac, hepatic or renal disease.
Drug Interactions:
Androgens may increase sensitivity to oral anticoagulants. Dosage of the anticoagulant may require reduction in order to maintain satisfactory therapeutic hypoprothrombinemia.
Concurrent administration of oxyphenbutazone and androgens may result in elevated serum levels of oxyphenbutazone.
In diabetic patients, the metabolic effects of androgens may decrease blood glucose and therefore insulin requirements.
Overdosage:
There have been no reports of acute overdosage with the androgens.